Main Menu

Translational Oncogenomics Team

Dr Marco Gerlinger's team investigates how cancer evolution and plasticity lead to resistance to cancer drugs and immunotherapies, with the aim of designing better treatments that prevent drug resistance.

Team leader

Dr Marco Gerlinger

Dr Marco Gerlinger

Dr Marco Gerlinger develops new tools to detect and track the evolution of cancer cells and of their microenvironment and better therapies which prevent the evolution of drug resistance. He holds an Honorary Consultant Medical Oncologist position at The Royal Marsden NHS Foundation Trust, where he treats patients with gastro-intestinal cancers. Based on the research in his lab, he performs clinical trials of novel immunotherapies that aim to leverage the immune system to attack cancer cells.

ORCID 0000-0003-2719-299X

Team members

Dr Marta Buzzetti

Postdoctoral Training Fellow

Dr Ben Challoner

PhD Student

Katie Cox

Scientific Officer +44 20 7153 5465

Camilla Cucinotta

Scientific Officer +44 20 7153 5596

Dr Hazel Lote

+44 20 7153 5427

Dr Neil McCafferty

Postdoctoral Training Fellow +44 20 7153 5495

Alice Newey

PhD Student

Maria Semiannikova

PhD Student +44 20 7153 5129

Renske van Boxtel

BSc Student

Dr Andrew Woolston

Postdoctoral Training Fellow +44 20 3437 7523